Nuvilex, Inc. Reaches Unofficial Starting Line of Its Phase 3 Pancreatic Cancer Clinical Trials NEW YORK, NY--(Marketwired - Nov 5, 2013) - Nuvilex, Inc. (OTCQB: NVLX) made an announcement yesterday that should have investors excited that the company's Phase 3 clinical trials may have...

MMM's John Harris Speaks at Entrepreneurs and Innovation Summit ATLANTA, GA--(Marketwire - January 29, 2009) - John Harris, Partner in the Intellectual Property Group at Morris, Manning & Martin, LLP, will speak on "Protecting Intellectual Property - Insights...